Rapid next generation infectious disease diagnostics for tuberculosis and leptospirosis

Infectious diseases remain one of the largest killers of the human population and disproportionately so in developing countries. Assays for the rapid and comprehensive identification of causative strains of the infectious disease agents in tuberculosis and leptospirosis is currently lacking. These infections represent over 20 million cases annually. Existing diagnostic protocols involve lengthy and resource-intensive procedures which substantially hinder the timely administration of treatment regimens. This project aims to combine cutting edge molecular biology protocols with next generation DNA sequencing and cloud computing resources to develop superior diagnostic assays for tuberculosis and leptospirosis. The intern will conduct the wet lab experiments required for developing these assays, bridging the molecular assay design steps with the cloud computing implementation of interpreting assay test results. The project objectives and logistical requirements are well matched to Fusion Genomics’ expertise and research mandate, in further developing the company’s suite of next generation clinical diagnostics products.

Faculty Supervisor:

Marcel Bally

Student:

Partner:

Fusion Genomics Corp

Discipline:

Life Sciences

Sector:

Manufacturing; Professional, scientific and technical services

University:

The University of British Columbia

Program: